Please use this identifier to cite or link to this item: https://doi.org/10.1186/s13756-016-0149-9
DC FieldValue
dc.titleCore components for effective infection prevention and control programmes: New WHO evidence-based recommendations
dc.contributor.authorStorr, J
dc.contributor.authorTwyman, A
dc.contributor.authorZingg, W
dc.date.accessioned2020-10-21T08:04:23Z
dc.date.available2020-10-21T08:04:23Z
dc.date.issued2017
dc.identifier.citationStorr, J, Twyman, A, Zingg, W (2017). Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations. Antimicrobial Resistance and Infection Control 6 (1) : 6. ScholarBank@NUS Repository. https://doi.org/10.1186/s13756-016-0149-9
dc.identifier.issn20472994
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/178711
dc.description.abstractHealth care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline. © 2017 World Health Organization.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectacute health care facility
dc.subjectantibiotic resistance
dc.subjectArticle
dc.subjectevidence based practice
dc.subjectgood clinical practice
dc.subjecthand washing
dc.subjecthealth care facility
dc.subjecthealth insurance
dc.subjecthealth program
dc.subjecthealthcare associated infection
dc.subjecthospital bed utilization
dc.subjectinfection control
dc.subjectinfection prevention
dc.subjectnational health service
dc.subjectpatient preference
dc.subjectpersonnel management
dc.subjectpoint of care system
dc.subjectpractice guideline
dc.subjectpriority journal
dc.subjectprogram effectiveness
dc.subjectworkload
dc.subjectworld health organization
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1186/s13756-016-0149-9
dc.description.sourcetitleAntimicrobial Resistance and Infection Control
dc.description.volume6
dc.description.issue1
dc.description.page6
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s13756-016-0149-9.pdf554.25 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons